Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
04 Março 2019 - 7:30PM
Edgar (US Regulatory)
Filed by Edge Therapeutics, Inc.
pursuant to Rule 425 under the Securities Act of 1933
and deemed filed under Rule 14a-6(b) of the Securities Exchange Act of 1934
Subject Company: Edge Therapeutics, Inc.
Commission File No. 001-37568
EDGE THERAPEUTICS, INC. (NASDAQ:EDGE)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
EDGE THERAPEUTICS, INC. (NASDAQ:EDGE)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Edge Therapeutics, Inc. da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Edge Therapeutics, Inc.